INTERCEPT PHARMACEUTICALS, INC.·4

Sep 6, 4:01 PM ET

Richardson Linda M 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Sep 6, 2022

Insider Transaction Report

Form 4
Period: 2022-09-01
Richardson Linda M
EVP & Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2022-09-01$18.06/sh597$10,78233,077 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file
  • 4
    tm2225103-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT